Neuroscience, Neurology and Psychiatry Gateway
Welcome to BioMed Central's Neuroscience, Neurology and Psychiatry Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.
Treatment of NV-01, a monoclonal canine-specific antibody against nerve growth factor, decreased pain and improved mobility in dogs with degenerative joint disease-associated pain, with the magnitude of the effect appearing identical to that expected with an NSAID.
Switching modes of signaling by β-catenin are associated with consecutive cell fate specificaton and progenitor proliferation to form the sensory neurons of dorsal root ganglia.
In psychosocial intervention research an attention placebo control is considered a valid control, though in practice suitable attention placebo controls are not often used. The methodological and ethical requirements are discussed, along with the need to adapt placebo research for psychosocial RCTs.
The ‘Emerging mental health systems in low- and middle-income countries’ (EMERALD) program aims to improve treatment and care of patients; Graham Thornicroft and colleagues discuss how EMERALD will strengthen mental health systems and reduce stigma.
Depression scales typically rely on quantifying the number of symptoms reported; Eiko Fried and Randolph Nesse argue that depressive symptoms differ from each other, and should be considered individually to assess the severity of depression.
BMC Neuroscience 2015, 16:28
Molecular Autism 2015, 6:23
BMC Anesthesiology 2015, 15:65
From the blog
News and events
Cerebellum & Ataxias, a new open access journal from BioMed Central, is now accepting submissions. Led by Editor-in-Chief Mario Manto, FNRS, Belgium, the journal hopes to mirror the success of its older, sister journal The Cerebellum, and complement its focus on the fundamental neurosciences of the cerebellum in providing a platform for more clinical cases and scientific reports of the numerous forms of ataxias.
Borderline Personality Disorder and Emotion Dysregulation (BPDED), a new independent journal, is now accepting submissions with BioMed Central. Overseen by an expert Editorial Board, BPDED provides a platform for researchers and clinicians interested in borderline personality disorder as a currently highly challenging psychiatric disorder, and welcomes contributions investigating the broad field of emotion dysregulation.
Acta Neuropathologica Communications is a new BioMed Central journal, edited by Werner Paulus. The journal publishes experimental and descriptive papers on the pathology of nervous system and skeletal muscle disorders and on mechanisms of neurological disease using morphological, molecular and cell biology methods. This is the sister journal to Acta Neuropathologica, published by Springer, which is also edited by Werner Paulus.